U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07514715) titled 'Proof of Concept for Real-time Multicentric Monitoring of MRD by PET and ctDNA in Aggressive B-Cell Lymphomas' on March 13.
Brief Summary: RT4 (REAL TIME TAILORED THERAPY) study was designed as a national, multicenter proof of concept aiming to demonstrate the technical and operational capacity of the French Connect network and the Positron Emission Tomography (PET) review network to ensure, within a coordinated framework, real time MINIMAL RESIDUAL DISEASE (MRD) monitoring through ctDNA analysis and centralized review of PET imaging.
Study Start Date: May, 2026
Study Type: OBSERVATIONAL
Condition:
Aggressive B-cell Lymphomas
I...